Director, Rare Disease Communications, EUCAN & International
17 hours ago
Barcelona
ppbLocation /b: Barcelona - Spain (3 days working from the office and 2 days working from home) /p pbWhat you’ll do: /b /p pThe bDirector, Rare Disease Communications /b, bEUCAN International /bwill provide communications expertise to the bEurope and Canada (EUCAN) /b and bInternational Region /b, including regional and market-level corporate and therapy area communications, internal communications, and executive leader visibility. /p pThe role reports to the bSenior Director, Rare Diseases Corporate Affairs, EUCAN /b and has dotted-line reporting to the bHead of Communications, Alexion /b and close business partnership with the bSenior Director, Rare Disease Corporate Affairs, International /b. The successful candidate will be highly collaborative, work closely with Market and Area Communication Directors across EUCAN, MEA, Latam, and AsiaPAC, as well as with global cross-functional teams, to advance and deliver a coordinated communications strategy that aligns regional business priorities and Global Corporate Affairs objectives. /p pExternal communications initiatives will predominantly focus on strengthening our corporate reputation as a trusted partner in rare disease, while supporting therapy area policy and market‑shaping efforts. Internal communications initiatives will predominantly focus on increasing employee engagement, equipping leaders to engage their teams, and inspiring change. /p pThe position will play a functional and strategic leadership role across the region, helping to further build bridges between Alexion and AstraZeneca, raise capabilities, and lead the network of in‑market communicators to optimise alignment, efficiency, and best practice. The role will also provide strategic counsel and guidance to the bSenior Vice President, EUCAN International, Alexion /b, working closely with them on executive communications and regional leadership visibility. /p h3Key Accountabilities /h3 pPlease note percentage time distributions are indicative only and workload distribution will ebb and flow in line with business priorities. /p h31. EUCAN International Communications Business Partnering (40%) /h3 ul liPartner with the bSVP, EUCAN International, Alexion /b to develop and deliver a strategic executive communications approach that strengthens bAlexion/AstraZeneca’s /b profile as a leader in rare disease. /li liLead and support executive thought leadership activities, including bspeaker platforms /b, bmedia engagement /b, and bLinkedIn platform management /b for the SVP. /li liDevelop and lead internal communications across bEUCAN International /b to increase employee engagement and support delivery of the business strategy. /li liOwn communications for the bEUCAN/International scorecard /b and related internal updates, including development of messaging and cascade of key priorities across the organisation. /li liDevelop and lead the communications plan for bSVP scorecard talent and development initiatives /b, ensuring strategic alignment with broader bHR communications /b across the organisation. /li liLead delivery of bregional town halls /b and contribute to bGlobal town hall /b agenda‑setting and content development. Support the SVP with local town halls and employee engagement during Country Visits. /li liLead bQuarterly Results internal communications /b, ensuring clear, consistent, and timely messaging for regional employees. /li liProvide communications support for bkey HR and change management communications /b, including people announcements for bSVP direct reports /b and strategic organisational developments. /li liContribute to bSenior Leadership Meeting (SLM) /b communications and the annual bAlexion Excellence Awards /b from the Alexion regional perspective. /li liManage the bAlexion EUCAN International WorkVivo page /b, ensuring it remains current, engaging, and aligned to business priorities. /li /ul h32. Regional Market Communications Partnering (40%) /h3 ul liProvide communications partnership to drive the bEUCAN International Corporate Affairs agenda /b, shaping and delivering communications strategies for key regional initiatives. /li liDevelop and lead communications strategies for bpriority Corporate Affairs projects and summits /b, especially across the International Region. /li liConvene the bmarket communications network /b to build community capabilities, ensuring all market communicators are able to adhere to newsflow, are using globally aligned practices and pull through of capability building programmes. /li liProactively identify best practice campaigns/communications approaches to elevate to global and/or other countries. /li liSupport in‑market bproduct communications /b through press release review, messaging alignment, and pull‑through of major congress and data milestones, where appropriate. /li liProvide bstrategic counsel /b to local communicators on bcrisis communications /b and business‑critical projects, including reputational issues. /li /ul h33. Global Strategic Contribution to and Pull Through of Alexion Corporate Affairs Priorities (20%) /h3 ul liContribute strategically to the development of the bAlexion global Corporate Affairs strategy /b, including helping to shape bscorecard priorities /b and communications planning. Support the pull those of those priorities in the markets. /li liSupport development and pull through of priority global communications deliverables and campaigns, such as bRare Disease Day /b. /li liParticipate in bglobal Alexion Corporate Affairs meetings /b to enable stronger bglobal‑to‑local co‑creation /b, alignment, and feedback. /li liRepresent the regional perspective within the broader bGlobal Corporate Affairs organisation /b, ensuring the needs of bRare Disease /b teams and markets are reflected appropriately in global plans. /li liSupport significant borganisational change programmes /b and breputation management activity /b across the region. /li liLead regional bscorecard reporting /b into bCEO Updates /b and other key business reporting mechanisms, ensuring communications outcomes and priorities are clearly reflected. /li /ul h3Education, Qualifications, Skills and Experience /h3 h3Essential for the role: /h3 ul liExtensive experience in the communications arena with minimum of 8 years of experience /li liStrong track record in delivering impactful internal and external communication strategies /li liStrong business acumen and proven success in connecting critical communications to business outcomes (industry experience preferred) /li liAbility to influence the business and communication decisions of senior management and to mentor senior leaders on their effectiveness /li liExperience in successful change communication programme implementation /li liExperience of crisis and/or issues management /li liPrior experience in media relations /li liProven track record of effectively managing many projects and resources /li liHighly‑developed cultural sensitivity and ability to work in virtual teams /li liKnowledge of and experience in working across geographic and cultural boundaries /li liFluent in English with excellent written and verbal communication skills and experience in a variety of media (speeches, fact sheets, briefings, executive presentations, news releases, etc) /li /ul h3Desirable for the role: /h3 ul liExpertise in Rare Diseases /li liExperience with medical product and data communications/news flow /li liFluency in an at least one major language (excluding English) desirable /li /ul h3Why AstraZeneca? /h3 pAt AstraZeneca we’re dedicated to being a Great Place to Work. Where you are empowered to push the boundaries of science and unleash your entrepreneurial spirit. There’s no better place to make a difference to medicine, patients and society. An inclusive culture that champions diversity and collaboration, and always committed to lifelong learning, growth and development. We’re on an exciting journey to pioneer the future of healthcare. /p h3Hybrid Working /h3 pWhen we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life‑changing medicines. In‑person working give us the platform we need to connect, work at pace and challenge perceptions. That’s why we work, on average, a minimum of three days per week from the office. But that doesn’t mean we’re not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world. /p h3So, what’s next? /h3 pAre you already imagining yourself joining our team? Good, because we can’t wait to hear from you! /p h3Date Posted /h3 p23-jul-2026 /p h3Closing Date /h3 p22-jul-2026 /p pAlexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lackthereof, sex, sexualorientation, age, ancestry, national origin, ethnicity, citizenship status, marital status,pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin aninteractive dialogue with Alexion regarding an accommodation, please contact Alexion participates in E-Verify. /p /p #J-18808-Ljbffr